Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Transplant Issues Author: Staff Editor Last Updated: Sep 7, 2017 - 10:06:33 PM



New Discovery Could Help Prevent Organ Transplant Rejection

By Staff Editor
Aug 24, 2016 - 9:47:02 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - PITTSBURGH, Aug. 24, 2016 - An international team led by researchers from the University of Pittsburgh School of Medicine found that targeting certain donor cells lowered the risk of organ rejection in mice that underwent kidney and heart transplants. The study results, published today in Nature Communications, could lead to new ways of preventing or treating organ transplant rejection in humans.

"The success of organ transplantation has reached a plateau over the past 10 or 20 years, with a significant proportion of patients still losing their grafts to rejection despite immunosuppressive treatment," said Fadi Lakkis, M.D., Frank & Athena Sarris Chair in Transplantation Biology, professor of surgery, immunology and surgery at the University of Pittsburgh, scientific director of the Thomas E. Starzl Transplantation Institute and co-author of the study.  "New methods to tackle rejection are needed, and this discovery is another step toward finding a solution."

Without immunosuppressive treatment, transplanted organs are quickly rejected by the recipient's immune system-in particular, by T cells. Successful engraftment has traditionally relied upon preventing the activation of T cells in the lymph nodes and spleen or in the graft by administering anti-rejection drugs. If T cell activation does occur, stopping rejection becomes increasingly difficult.

To become fully activated, T cells need to make physical contact and receive help from a highly specialized type of cell called dendritic cells. Post-transplant, the main function of the dendritic cells is to present donor-derived antigens to donor-reactive T cells in lymphoid tissues, causing an immune response in the body.

In the study, researchers found that dendritic cells play a key role in driving rejection of transplanted organs by activated T cells that have already entered the transplanted organ. The donor dendritic cells that accompanied heart or kidney grafts in mice were rapidly replaced by the recipient's dendritic cells, which propagated T lymphocyte activation within the graft and increased the risk of rejection.

"We demonstrated that dendritic cells not only exert a key role as antigen-presenting cells in graft-draining lymphoid organs, but also play a critical function within the transplanted organs," said Adrian E. Morelli, M.D., Ph.D., associate professor of surgery and immunology at the Thomas E. Starzl Transplantation Institute and study co-author. "Our study indicates that eliminating transplant-infiltrating dendritic cells reduces proliferation and survival of T cells within the graft with the consequent prolongation of transplant survival."

"The next step would be to devise methods to specifically target dendritic cells within transplanted organs," Dr. Lakkis said. "Such methods carry the promise of preventing or interrupting rejection without compromising the patient's overall immune defenses."

The study was supported in part by grants from the National Institutes of Health(R01AI049466, R01AI099465, R01HL130191), American Society of Nephrology,American Heart Association, and National Natural Science Foundation of China.

#  #  #

About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.

Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see www.medschool.pitt.edu.

###

For advertising/promo please contact Mike McCurdy at [email protected] or 877-634-9180



Top of Page

HealthNewsDigest.com

Transplant Issues
Latest Headlines


+ Scientists Create Successful Mass Production System for Bioengineered Livers
+ Mayo’s First Face Transplant Patient Meets Donor’s Family (VIDEO)
+ Older Donor Lungs Should Be Considered For Transplantation
+ VA Patients Face Disparities in Kidney Transplantation
+ Mom is Grateful for Her Son’s Bone Marrow Transplant
+ New Way to Treat Inflammatory Gut Disease and Prevent Rejection of Bone Marrow Transplants
+ Kidney Transplantation May Prolong the Survival of Patients on Long-Term Dialysis
+ One Liver. Two Saved Lives
+ ‘Increased Risk’ Donor Organs a Tough Sell to Transplant Patients
+ HCV Guidance Website Address Kidney Transplantation, Pregnancy and HCV in Children



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions